Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $51.02 $63.08 Friday, 10th May 2024 CRSP stock ended at $51.17. This is 4.44% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 7.59% from a day low at $51.02 to a day high of $54.89.
90 days $51.02 $91.10
52 weeks $37.55 $91.10

Historical CRISPR Therapeutics AG prices

Date Open High Low Close Volume
Apr 05, 2024 $64.40 $64.45 $62.35 $62.90 1 676 289
Apr 04, 2024 $64.83 $67.25 $64.67 $65.06 1 214 901
Apr 03, 2024 $64.73 $65.46 $63.62 $64.60 992 985
Apr 02, 2024 $66.00 $66.39 $64.30 $65.03 1 494 668
Apr 01, 2024 $68.15 $68.39 $66.50 $68.18 1 059 585
Mar 28, 2024 $69.98 $70.12 $67.52 $68.16 1 599 396
Mar 27, 2024 $71.49 $71.49 $68.88 $70.16 1 334 477
Mar 26, 2024 $71.29 $73.09 $70.89 $70.97 835 212
Mar 25, 2024 $71.55 $72.04 $70.81 $71.08 906 778
Mar 22, 2024 $74.50 $74.59 $71.55 $71.61 1 022 361
Mar 21, 2024 $73.78 $75.91 $73.18 $74.50 1 481 091
Mar 20, 2024 $71.51 $74.20 $70.70 $72.94 1 277 106
Mar 19, 2024 $71.09 $72.66 $70.36 $71.96 1 292 459
Mar 18, 2024 $73.57 $73.71 $71.24 $71.47 1 210 589
Mar 15, 2024 $71.78 $73.50 $71.40 $72.95 1 936 287
Mar 14, 2024 $73.53 $74.16 $71.13 $72.01 1 726 751
Mar 13, 2024 $74.61 $76.86 $74.00 $74.78 1 226 277
Mar 12, 2024 $76.20 $76.20 $73.66 $75.30 1 408 732
Mar 11, 2024 $78.48 $79.33 $76.12 $76.82 1 404 664
Mar 08, 2024 $79.54 $81.72 $77.16 $78.92 1 613 068
Mar 07, 2024 $81.00 $83.50 $79.32 $79.37 1 198 639
Mar 06, 2024 $81.58 $81.96 $79.50 $80.83 1 087 991
Mar 05, 2024 $80.17 $82.87 $79.00 $80.99 1 382 355
Mar 04, 2024 $83.98 $84.17 $80.50 $81.74 1 601 277
Mar 01, 2024 $84.36 $87.08 $83.33 $83.75 1 414 345
Click to get the best stock tips daily for free!

About CRISPR Therapeutics AG

CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo... CRSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT